Literature DB >> 30741074

Correlations between dopaminergic dysfunction and abnormal metabolic network activity in REM sleep behavior disorder.

Zhemin Huang1, Chengfeng Jiang2, Ling Li1, Qian Xu1, Jingjie Ge1, Ming Li1, Yihui Guan1,3, Jianjun Wu4,5, Jian Wang4,5, Chuantao Zuo1,3, Huan Yu4,6, Ping Wu1.   

Abstract

Striatal dopamine transporter (DAT) deficiency and abnormal expression of Parkinson's disease (PD)-related pattern (PDRP) have been observed in patients with idiopathic REM sleep behavior disorder (IRBD). This study aimed to investigate the correlations between these two measures with comparison to PD using a dual tracer imaging design. Age-matched 37 IRBD patients, 86 PD patients, and 15 control subjects underwent concurrent PET scans with 11C-CFT to quantify dopaminergic dysfunction and 18F-FDG to quantify PDRP expression. IRBD patients were divided into two subgroups: those with relatively normal (IRBD-RN) or abnormal (IRBD-AB) striatal DAT binding. Significantly decreased DAT binding and increased PDRP scores were present in all patient groups, except for IRBD-RN, relative to the controls. There was a significant effect of hemisphere and hemisphere × group interaction for DAT binding but not for PDRP expression. Significant correlations were observed between DAT binding and PDRP expression in the IRBD-AB and PD groups but not in the IRBD-RN group. IRBD patients present with an intermediate state in striatal DAT distribution and PDRP activity between PD and normal controls. The modest correlations between the two measures in both IRBD and PD suggest that differences in network activity cannot be fully explained by nigrostriatal dopaminergic denervation.

Entities:  

Keywords:  Dopamine transporter; Parkinson's disease; metabolic brain network; positron emission tomography; rapid-eye-movement sleep behavior disorder

Mesh:

Substances:

Year:  2019        PMID: 30741074      PMCID: PMC7026846          DOI: 10.1177/0271678X19828916

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  41 in total

1.  Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls.

Authors:  I Eisensehr; R Linke; S Noachtar; J Schwarz; F J Gildehaus; K Tatsch
Journal:  Brain       Date:  2000-06       Impact factor: 13.501

2.  Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.

Authors:  Alex Iranzo; Francesc Valldeoriola; Francisco Lomeña; José Luis Molinuevo; Mónica Serradell; Manel Salamero; Albert Cot; Domènec Ros; Javier Pavía; Joan Santamaria; Eduardo Tolosa
Journal:  Lancet Neurol       Date:  2011-07-28       Impact factor: 44.182

Review 3.  Trial designs used to study neuroprotective therapy in Parkinson's disease.

Authors:  Anthony E Lang; Eldad Melamed; Werner Poewe; Olivier Rascol
Journal:  Mov Disord       Date:  2012-08-23       Impact factor: 10.338

4.  Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake.

Authors:  H T Benamer; J Patterson; D J Wyper; D M Hadley; G J Macphee; D G Grosset
Journal:  Mov Disord       Date:  2000-07       Impact factor: 10.338

5.  Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.

Authors:  Morten Gersel Stokholm; Alex Iranzo; Karen Østergaard; Mónica Serradell; Marit Otto; Kristina Bacher Svendsen; Alicia Garrido; Dolores Vilas; Per Borghammer; Joan Santamaria; Arne Møller; Carles Gaig; David J Brooks; Eduardo Tolosa; Nicola Pavese
Journal:  Lancet Neurol       Date:  2017-07-03       Impact factor: 44.182

Review 6.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

7.  Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease.

Authors:  S A Eshuis; R P Maguire; K L Leenders; S Jonkman; P L Jager
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-15       Impact factor: 9.236

8.  Metabolic brain network in the Chinese patients with Parkinson's disease based on 18F-FDG PET imaging.

Authors:  Ping Wu; Jian Wang; Shichun Peng; Yilong Ma; Huiwei Zhang; Yihui Guan; Chuantao Zuo
Journal:  Parkinsonism Relat Disord       Date:  2013-03-23       Impact factor: 4.891

9.  Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series.

Authors:  Carlos H Schenck; Bradley F Boeve; Mark W Mahowald
Journal:  Sleep Med       Date:  2013-01-22       Impact factor: 3.492

10.  Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.

Authors:  K Stiasny-Kolster; Y Doerr; J C Möller; H Höffken; T M Behr; W H Oertel; G Mayer
Journal:  Brain       Date:  2004-11-17       Impact factor: 13.501

View more
  13 in total

1.  Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients.

Authors:  Pietro Mattioli; Matteo Pardini; Francesco Famà; Nicola Girtler; Andrea Brugnolo; Beatrice Orso; Riccardo Meli; Laura Filippi; Stefano Grisanti; Federico Massa; Matteo Bauckneht; Alberto Miceli; Michele Terzaghi; Silvia Morbelli; Flavio Nobili; Dario Arnaldi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-28       Impact factor: 9.236

2.  The Parkinson's Disease Progression Neuroimaging Initiative.

Authors:  Shiyi Zhu; Zizhao Ju; Ping Wu; Fengtao Liu; Jingjie Ge; Huiwei Zhang; Jiaying Lu; Ling Li; Min Wang; Jiehui Jiang; Jian Wang; Chuantao Zuo
Journal:  Behav Neurol       Date:  2021-12-30       Impact factor: 3.342

3.  Decoding the dopamine transporter imaging for the differential diagnosis of parkinsonism using deep learning.

Authors:  Yu Zhao; Jianjun Wu; Ping Wu; Matthias Brendel; Jiaying Lu; Jingjie Ge; Chunmeng Tang; Jimin Hong; Qian Xu; Fengtao Liu; Yimin Sun; Zizhao Ju; Huamei Lin; Yihui Guan; Claudio Bassetti; Markus Schwaiger; Sung-Cheng Huang; Axel Rominger; Jian Wang; Chuantao Zuo; Kuangyu Shi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-05-19       Impact factor: 10.057

4.  Characterizing the heterogeneous metabolic progression in idiopathic REM sleep behavior disorder.

Authors:  Xianhua Han; Ping Wu; Ian Alberts; Hucheng Zhou; Huan Yu; Panagiotis Bargiotas; Igor Yakushev; Jian Wang; Guenter Höglinger; Stefan Förster; Claudio Bassetti; Wolfgang Oertel; Markus Schwaiger; Sung-Cheng Huang; Paul Cumming; Axel Rominger; Jiehui Jiang; Chuantao Zuo; Kuangyu Shi
Journal:  Neuroimage Clin       Date:  2020-05-26       Impact factor: 4.881

5.  Quality of life in Parkinson's disease: A systematic review and meta-analysis of comparative studies.

Authors:  Na Zhao; Yuan Yang; Ling Zhang; Qinge Zhang; Lloyd Balbuena; Gabor S Ungvari; Yu-Feng Zang; Yu-Tao Xiang
Journal:  CNS Neurosci Ther       Date:  2020-12-28       Impact factor: 5.243

6.  Dopaminergic and Metabolic Correlations With Cognitive Domains in Non-demented Parkinson's Disease.

Authors:  Linlin Han; Jiaying Lu; Yilin Tang; Yun Fan; Qisi Chen; Ling Li; Fengtao Liu; Jian Wang; Chuantao Zuo; Jue Zhao
Journal:  Front Aging Neurosci       Date:  2021-02-16       Impact factor: 5.750

Review 7.  Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.

Authors:  Sanne K Meles; Wolfgang H Oertel; Klaus L Leenders
Journal:  Mol Med       Date:  2021-09-16       Impact factor: 6.354

Review 8.  Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder.

Authors:  Mitchell G Miglis; Charles H Adler; Elena Antelmi; Dario Arnaldi; Luca Baldelli; Bradley F Boeve; Matteo Cesari; Irene Dall'Antonia; Nico J Diederich; Kathrin Doppler; Petr Dušek; Raffaele Ferri; Jean-François Gagnon; Ziv Gan-Or; Wiebke Hermann; Birgit Högl; Michele T Hu; Alex Iranzo; Annette Janzen; Anastasia Kuzkina; Jee-Young Lee; Klaus L Leenders; Simon J G Lewis; Claudio Liguori; Jun Liu; Christine Lo; Kaylena A Ehgoetz Martens; Jiri Nepozitek; Giuseppe Plazzi; Federica Provini; Monica Puligheddu; Michal Rolinski; Jan Rusz; Ambra Stefani; Rebekah L S Summers; Dallah Yoo; Jennifer Zitser; Wolfgang H Oertel
Journal:  Lancet Neurol       Date:  2021-08       Impact factor: 44.182

9.  A Fully Automatic Framework for Parkinson's Disease Diagnosis by Multi-Modality Images.

Authors:  Jiahang Xu; Fangyang Jiao; Yechong Huang; Xinzhe Luo; Qian Xu; Ling Li; Xueling Liu; Chuantao Zuo; Ping Wu; Xiahai Zhuang
Journal:  Front Neurosci       Date:  2019-08-23       Impact factor: 4.677

Review 10.  Brain-First versus Gut-First Parkinson's Disease: A Hypothesis.

Authors:  Per Borghammer; Nathalie Van Den Berge
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.